The role of E-selectin in inflammatory and atherogenic processes - the impact of hormonal therapy of the menopausal period
Journal Title: Przegląd Menopauzalny - Year 2006, Vol 25, Issue 3
Abstract
E-selectin plays a very important role in phlogistic and atherosclerotic processes of the human organism. Expression of this membrane protein is found on inflammatory endothelial cells as a result of the action of pro-inflammatory cytokines. This protein is also present on atheromatous endothelium with coexisting leucocytic infiltrations. Hormone therapy of the menopausal period favourably reduces E-selectin levels, however this effect is dependent on hormonal doses, type of estrogen and progestogen used as well as on menopausal age, accompanying illnesses and addictions of women qualified for this type of treatment.
Authors and Affiliations
Grzegorz Stachowiak, Tomasz Stetkiewicz, Ireneusz Połać, Anna Sobczuk, Sławomir Jędrzejczyk
Keywords
Related Articles
- EP ID EP83679
- DOI -
- Views 62
- Downloads 0
Wpływ HTZ na choroby układu sercowo-naczyniowego – przegląd piśmiennictwa
W artykule autorzy omawiają wpływ HTZ (hormonalnej terapii zastępczej) i ETZ (estrogenowej terapii zastępczej) na częstość występowania chorób układu sercowo-naczyniowego. Brak zgodności pomiędzy wnioskami wynikającymi z...
The increaased breast mammographic density as an adverse effect of menopausal hormonal therapy
The influence of menopausal hormonal therapy (HT) on the breast remains one of the crucial aspects of the menopausal medicine. In this context the jatrogenic deterioration of the mammographic examination sensitivity du...
The influence of 17beta-estradiol and norethisterone acetate given transdermally and low doses of acetylsalicylic acid on some selected parameters of coagulation and fibrinolysis in menopausal women with some risk factors for coronary heart disease
Aim of study: 1) The impact of transdermal hormone therapy (tHT) on coagulation and fibrinolysis of menopausal women with risk factors for coronary heart disease (CHD). 2) The usefulness of combining this therapy with so...
Rola inhibitora aktywatora plazminogenu 1 (PAI-1) po menopauzie – wpływ terapii hormonalnej tego okresu
PAI-1 to ważny inhibitor w układzie fibrynolizy. W artykule przedstawiono związek tej glikoproteiny z chorobami układu krążenia, otyłością i nowotworami w grupie kobiet pomenopauzalnych. Podwyższony poziom PAI-1 po men...
Female urinary incontinence - should we always perform surgery?
There are a lot of factors engaged in the etiopathogenesis of urinary incontinence. The algorythym of diagnosis and treatment of female urinary incontinence is very complicated. The sufficient terapeutic options is depen...